{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:09:18Z","timestamp":1787292558237,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Pept Res Ther"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10989-021-10218-8","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T07:41:55Z","timestamp":1619336515000},"page":"1885-1898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Designing of a Novel Fusion Protein Vaccine Candidate Against Human Visceral Leishmaniasis (VL) Using Immunoinformatics and Structural Approaches"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6149-6423","authenticated-orcid":false,"given":"Amir","family":"Atapour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Ghalamfarsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Hatam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"issue":"3","key":"10218_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/vaccines8030350","volume":"8","author":"M Agallou","year":"2020","unstructured":"Agallou M et al (2020) A canine-directed chimeric multi-epitope vaccine induced protective immune responses in BALB\/c Mice infected with leishmania infantum. Vaccines 8(3):350","journal-title":"Vaccines"},{"issue":"4","key":"10218_CR2","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s10989-019-09980-7","volume":"26","author":"F Ahmadi","year":"2020","unstructured":"Ahmadi F et al (2020) In silico design of epitope-based allergy vaccine against bellatella germanica cockroach allergens. Int J Pept Res Ther 26(4):1739\u20131749","journal-title":"Int J Pept Res Ther"},{"issue":"4","key":"10218_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","volume":"32","author":"M Andreatta","year":"2016","unstructured":"Andreatta M, Nielsen M (2016) Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics 32(4):511\u2013517","journal-title":"Bioinformatics"},{"issue":"1","key":"10218_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1745-7580-6-6","volume":"6","author":"HR Ansari","year":"2010","unstructured":"Ansari HR, Raghava GP (2010) Identification of conformational B-cell Epitopes in an antigen from its primary sequence. Immunome Res 6(1):6","journal-title":"Immunome Res"},{"key":"10218_CR5","first-page":"38","volume":"30","author":"A Atapour","year":"2017","unstructured":"Atapour A et al (2017) Molecular cloning, expression, and purification of a recombinant fusion protein (rNT-gp96-NT300). BioPharm Int 30:38\u201344","journal-title":"BioPharm Int"},{"issue":"3","key":"10218_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10989-018-9735-4","volume":"25","author":"A Atapour","year":"2019","unstructured":"Atapour A et al (2019) Designing a fusion protein vaccine against HCV: an in silico approach. Int J Pept Res Ther 25(3):861\u2013872","journal-title":"Int J Pept Res Ther"},{"issue":"1","key":"10218_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10989-019-09843-1","volume":"26","author":"A Atapour","year":"2020","unstructured":"Atapour A et al (2020) In silico designing a candidate vaccine against breast cancer. Int J Pept Res Ther 26(1):369\u2013380","journal-title":"Int J Pept Res Ther"},{"key":"10218_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-308X(06)64001-3","volume":"64","author":"A-L Banuls","year":"2007","unstructured":"Banuls A-L et al (2007) Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol 64:1\u2013458","journal-title":"Adv Parasitol"},{"issue":"11","key":"10218_CR9","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"R Basu","year":"2005","unstructured":"Basu R et al (2005) Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and-resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1-and Th2-like responses in visceral leishmaniasis. J Immunol 174(11):7160\u20137171","journal-title":"J Immunol"},{"issue":"W1","key":"10218_CR10","doi-asserted-by":"publisher","first-page":"W402","DOI":"10.1093\/nar\/gkz297","volume":"47","author":"DW Buchan","year":"2019","unstructured":"Buchan DW, Jones DT (2019) The PSIPRED protein analysis workbench: 20 years on. Nucleic Acids Res 47(W1):W402\u2013W407","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10218_CR11","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro1748z","volume":"5","author":"F Chappuis","year":"2007","unstructured":"Chappuis F et al (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5(11):S7\u2013S16","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"10218_CR12","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X et al (2013) Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev 65(10):1357\u20131369","journal-title":"Adv Drug Deliv Rev"},{"key":"10218_CR13","doi-asserted-by":"crossref","unstructured":"Cheng, J., et al. (2005). \"SCRATCH: a protein structure and structural feature prediction server.\" Nucleic acids research 33(suppl_2): W72-W76.","DOI":"10.1093\/nar\/gki396"},{"issue":"4","key":"10218_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","volume":"33","author":"RL Coffman","year":"2010","unstructured":"Coffman RL et al (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33(4):492\u2013503","journal-title":"Immunity"},{"issue":"9","key":"10218_CR15","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates T (1993) ERRAT: an empirical atom-based method for validating protein structures. Protein Sci 2(9):1511\u20131519","journal-title":"Protein Sci"},{"issue":"1","key":"10218_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-S19-S1","volume":"14","author":"DB Craig","year":"2013","unstructured":"Craig DB, Dombkowski AA (2013) Disulfide by Design 2.0: a web-based tool for disulfide engineering in proteins. BMC Bioinformatics 14(1):1\u20137","journal-title":"BMC Bioinformatics"},{"issue":"8","key":"10218_CR17","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1007\/s00253-019-09691-5","volume":"103","author":"B Cui","year":"2019","unstructured":"Cui B et al (2019) Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin. Appl Microbiol Biotechnol 103(8):3367\u20133379","journal-title":"Appl Microbiol Biotechnol"},{"key":"10218_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fimmu.2015.00524","volume":"6","author":"SCF de Mendon\u00e7a","year":"2015","unstructured":"de Mendon\u00e7a SCF et al (2015) Kinetoplastid membrane protein-11 as a vaccine candidate and a virulence factor in Leishmania. Front Immunol 6:524","journal-title":"Front Immunol"},{"issue":"1","key":"10218_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda SK et al (2013) Designing of interferon-gamma inducing MHC class-II binders. Biol Direct 8(1):30","journal-title":"Biol Direct"},{"issue":"4","key":"10218_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jmr.893","volume":"21","author":"Y EL-Manzalawy","year":"2008","unstructured":"EL-Manzalawy Y et al (2008) Predicting linear B-cell epitopes using string kernels. J Mol Recogni: An Interdisciplinary Journal 21(4):243\u2013255","journal-title":"J Mol Recogni: An Interdisciplinary Journal"},{"issue":"2","key":"10218_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10989-018-9698-5","volume":"25","author":"I Farhani","year":"2019","unstructured":"Farhani I et al (2019) Designing a novel multi-epitope peptide vaccine against pathogenic Shigella spp. based immunoinformatics approaches. Int J Pept Res Ther 25(2):541\u2013553","journal-title":"Int J Pept Res Ther"},{"key":"10218_CR22","first-page":"571","volume-title":"Protein identification and analysis tools on the ExPASy server","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger E et al (2005) Protein identification and analysis tools on the ExPASy server. Springer, The proteomics protocols handbook, pp 571\u2013607"},{"key":"10218_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/DDDT.S146521","volume":"12","author":"M Ghorbani","year":"2018","unstructured":"Ghorbani M, Farhoudi R (2018) Leishmaniasis in humans: drug or vaccine therapy? Drug Des Dev Ther 12:25","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"10218_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/14760584.3.1.59","volume":"3","author":"ASD Groot","year":"2004","unstructured":"Groot ASD, Rappuoli R (2004) Genome-derived vaccines. Expert Rev Vaccines 3(1):59\u201376","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10218_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote A et al (2005) JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 33(2):526\u2013531","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10218_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4314\/ejhs.v26i4.10","volume":"26","author":"F Heydarpour","year":"2016","unstructured":"Heydarpour F et al (2016) Incidence and disability-adjusted life years (Dalys) attributable to leishmaniasis in Iran, 2013. Ethiop J Health Sci 26(4):381\u2013388","journal-title":"Ethiop J Health Sci"},{"issue":"8","key":"10218_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/microorganisms8081201","volume":"8","author":"NM Ikeogu","year":"2020","unstructured":"Ikeogu NM et al (2020) Leishmania immunity: advancing immunotherapy and vaccine development. Microorganisms 8(8):1201","journal-title":"Microorganisms"},{"key":"10218_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2020.01.007","volume":"65","author":"DJ Irvine","year":"2020","unstructured":"Irvine DJ, Read BJ (2020) Shaping humoral immunity to vaccines through antigen-displaying nanoparticles. Curr Opin Immunol 65:1\u20136","journal-title":"Curr Opin Immunol"},{"key":"10218_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","volume":"422","author":"K Jain","year":"2015","unstructured":"Jain K, Jain N (2015) Vaccines for visceral leishmaniasis: A review. J Immunol Methods 422:1\u201312","journal-title":"J Immunol Methods"},{"issue":"3","key":"10218_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/imm.12889","volume":"154","author":"KK Jensen","year":"2018","unstructured":"Jensen KK et al (2018) Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology 154(3):394\u2013406","journal-title":"Immunology"},{"key":"10218_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fimmu.2014.00380","volume":"5","author":"S Joshi","year":"2014","unstructured":"Joshi S et al (2014) Visceral leishmaniasis: advancements in vaccine development via classical and molecular approaches. Front Immunol 5:380","journal-title":"Front Immunol"},{"key":"10218_CR32","doi-asserted-by":"crossref","unstructured":"Ka, T., et al. (2020). \"A Candidate multi-epitope vaccine against SARS-CoV-2.\"","DOI":"10.21203\/rs.3.rs-28130\/v1"},{"issue":"10","key":"10218_CR33","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/j.1469-0691.2011.03610.x","volume":"17","author":"P Kaye","year":"2011","unstructured":"Kaye P, Aebischer T (2011) Visceral leishmaniasis: immunology and prospects for a vaccine. Clin Microbiol Infect 17(10):1462\u20131470","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10218_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","volume":"33","author":"I Kevric","year":"2015","unstructured":"Kevric I et al (2015) New world and old world Leishmania infections: a practical review. Dermatol Clin 33(3):579\u2013593","journal-title":"Dermatol Clin"},{"issue":"3","key":"10218_CR35","first-page":"423","volume":"123","author":"A Khamesipour","year":"2006","unstructured":"Khamesipour A et al (2006) Leishmaniasis vaccine candidates for development: a global overview. Indian J Med Res 123(3):423","journal-title":"Indian J Med Res"},{"key":"10218_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-020-04064-8","volume":"13","author":"MAA Khan","year":"2020","unstructured":"Khan MAA et al (2020) An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes. Parasit Vectors 13:1\u201321","journal-title":"Parasit Vectors"},{"issue":"1","key":"10218_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08842-w","volume":"7","author":"N Khatoon","year":"2017","unstructured":"Khatoon N et al (2017) Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach. Sci Rep 7(1):1\u201312","journal-title":"Sci Rep"},{"issue":"12","key":"10218_CR38","doi-asserted-by":"publisher","first-page":"e1002829","DOI":"10.1371\/journal.pcbi.1002829","volume":"8","author":"JV Kringelum","year":"2012","unstructured":"Kringelum JV et al (2012) Reliable B cell epitope predictions: impacts of method development and improved benchmarking. PLoS Comput Biol 8(12):e1002829","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"10218_CR39","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1038\/cti.2014.4","volume":"3","author":"R Kumar","year":"2014","unstructured":"Kumar R, Engwerda C (2014) Vaccines to prevent leishmaniasis. Clini Translat Immunol 3(3):e13","journal-title":"Clini Translat Immunol"},{"issue":"W1","key":"10218_CR40","doi-asserted-by":"publisher","first-page":"W338","DOI":"10.1093\/nar\/gky356","volume":"46","author":"A Kuriata","year":"2018","unstructured":"Kuriata A et al (2018) CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures. Nucleic Acids Res 46(W1):W338\u2013W343","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10218_CR41","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen MV et al (2007) Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8(1):424","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"10218_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1021\/mp500520r","volume":"12","author":"JW Lockner","year":"2015","unstructured":"Lockner JW et al (2015) Flagellin as carrier and adjuvant in cocaine vaccine development. Mol Pharm 12(2):653\u2013662","journal-title":"Mol Pharm"},{"key":"10218_CR43","doi-asserted-by":"crossref","unstructured":"Lovell, S. C., et al. (2003) Structure validation by C\u03b1 geometry \u03d5, \u03c8 and C\u03b2 deviation. Proteins: Structure, Function, and Bioinformatics 50(3): 437\u2013450.","DOI":"10.1002\/prot.10286"},{"issue":"1","key":"10218_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"Y Lu","year":"2016","unstructured":"Lu Y, Swartz JR (2016) Functional properties of flagellin as a stimulator of innate immunity. Sci Rep 6(1):1\u201311","journal-title":"Sci Rep"},{"issue":"9","key":"10218_CR45","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14760584.2020.1811091","volume":"19","author":"SR Mahapatra","year":"2020","unstructured":"Mahapatra SR et al (2020) Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection. Expert Rev Vaccines 19(9):871\u2013885","journal-title":"Expert Rev Vaccines"},{"key":"10218_CR46","doi-asserted-by":"crossref","unstructured":"Mahboobi, M., et al. (2020). \"Harnessing an Integrative In Silico Approach to Engage Highly Immunogenic Peptides in an Antigen Design Against Epsilon Toxin (ETX) of Clostridium perfringens.\" International Journal of Peptide Research and Therapeutics: 1\u20138.","DOI":"10.1007\/s10989-020-10147-y"},{"key":"10218_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.micpath.2018.03.016","volume":"118","author":"M Makvandi","year":"2018","unstructured":"Makvandi M et al (2018) Expression of Salmonella typhimurium and Escherichia coli flagellin protein and its functional characterization as an adjuvant. Microb Pathog 118:87\u201390","journal-title":"Microb Pathog"},{"key":"10218_CR48","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.69273","volume-title":"The impact of bioinformatics on vaccine design and development","author":"R Mar\u00eda","year":"2017","unstructured":"Mar\u00eda R et al (2017) The impact of bioinformatics on vaccine design and development. Vaccines, InTech, Rijeka, Croatia"},{"issue":"12","key":"10218_CR49","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.4049\/jimmunol.170.12.6217","volume":"170","author":"SB Mizel","year":"2003","unstructured":"Mizel SB et al (2003) Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5\/Toll-like receptor 4 complexes. J Immunol 170(12):6217\u20136223","journal-title":"J Immunol"},{"issue":"2","key":"10218_CR50","first-page":"144","volume":"11","author":"V Nasiri","year":"2016","unstructured":"Nasiri V et al (2016) Immunogenicity and efficacy of live L. tarentolae expressing KMP11-NTGP96-GFP fusion as a vaccine candidate against experimental Visceral Leishmaniasis caused by L. infantum. Iran J Parasitol 11(2):144","journal-title":"Iran J Parasitol"},{"key":"10218_CR51","first-page":"251","volume":"3","author":"S Nyl\u00e9n","year":"2012","unstructured":"Nyl\u00e9n S, Kumar R (2012) Immunobiology of visceral leishmaniasis. Front Immunol 3:251","journal-title":"Front Immunol"},{"issue":"5","key":"10218_CR52","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4161\/hv.5.5.7607","volume":"5","author":"I Okwor","year":"2009","unstructured":"Okwor I, Uzonna J (2009) Vaccines and vaccination strategies against human cutaneous leishmaniasis. Hum Vaccin 5(5):291\u2013301","journal-title":"Hum Vaccin"},{"key":"10218_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/ITT.S241064","volume":"9","author":"AN Oli","year":"2020","unstructured":"Oli AN et al (2020) Immunoinformatics and vaccine development: an overview. ImmunoTargets and therapy 9:13","journal-title":"ImmunoTargets and therapy"},{"issue":"20","key":"10218_CR54","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1016\/j.vaccine.2010.03.031","volume":"28","author":"GA Poland","year":"2010","unstructured":"Poland GA, Oberg AL (2010) Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology. Vaccine 28(20):3509","journal-title":"Vaccine"},{"issue":"3","key":"10218_CR55","first-page":"277","volume":"22","author":"T Polonio","year":"2008","unstructured":"Polonio T, Efferth T (2008) Leishmaniasis: drug resistance and natural products. Int J Mol Med 22(3):277\u2013286","journal-title":"Int J Mol Med"},{"issue":"12","key":"10218_CR56","doi-asserted-by":"publisher","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","volume":"11","author":"A Ponte-Sucre","year":"2017","unstructured":"Ponte-Sucre A et al (2017) Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis 11(12):e0006052","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10218_CR57","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy A et al (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5(4):725\u2013738","journal-title":"Nat Protoc"},{"key":"10218_CR58","doi-asserted-by":"crossref","unstructured":"Saha, S. and G. Raghava (2006). \"AlgPred: prediction of allergenic proteins and mapping of IgE epitopes.\" Nucleic acids research 34(suppl_2): W202-W209.","DOI":"10.1093\/nar\/gkl343"},{"issue":"1","key":"10218_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha S, Raghava GPS (2006) Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins: Struct, Funct, Bioinf 65(1):40\u201348","journal-title":"Proteins: Struct, Funct, Bioinf"},{"key":"10218_CR60","doi-asserted-by":"crossref","unstructured":"Senevirathne, A., et al. (2020) Parenteral immunization of Salmonella Typhimurium ghosts with surface-displayed Escherichia coli flagellin enhancesTLR-5 mediated activation of immune responses that protect the chicken against Salmonella infection.\" Microbial pathogenesis: 104252.","DOI":"10.1016\/j.micpath.2020.104252"},{"issue":"10","key":"10218_CR61","first-page":"1810","volume":"25","author":"I Silva-Jardim","year":"2014","unstructured":"Silva-Jardim I et al (2014) Leishmaniasis and Chagas disease chemotherapy: a critical review. J Braz Chem Soc 25(10):1810\u20131823","journal-title":"J Braz Chem Soc"},{"issue":"1","key":"10218_CR62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","volume":"9","author":"S Srivastava","year":"2016","unstructured":"Srivastava S et al (2016) Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasit Vectors 9(1):277","journal-title":"Parasit Vectors"},{"key":"10218_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fimmu.2012.00005","volume":"3","author":"S Stager","year":"2012","unstructured":"Stager S, Rafati S (2012) CD8+ T cells in Leishmania infections: friends or foes? Front Immunol 3:5","journal-title":"Front Immunol"},{"issue":"17","key":"10218_CR64","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","volume":"29","author":"F Steinhagen","year":"2011","unstructured":"Steinhagen F et al (2011) TLR-based immune adjuvants. Vaccine 29(17):3341\u20133355","journal-title":"Vaccine"},{"issue":"1","key":"10218_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678707.2019.1552853","volume":"7","author":"S Sundar","year":"2019","unstructured":"Sundar S et al (2019) Leishmaniasis: treatment, drug resistance and emerging therapies. Expert Opin Orphan Drugs 7(1):1\u201310","journal-title":"Expert Opin Orphan Drugs"},{"key":"10218_CR66","first-page":"181","volume-title":"Predicting the structure of protein\u2013protein complexes using the SwarmDock web server","author":"M Torchala","year":"2014","unstructured":"Torchala M, Bates PA (2014) Predicting the structure of protein\u2013protein complexes using the SwarmDock web server. Springer, Protein structure prediction, pp 181\u2013197"},{"issue":"2","key":"10218_CR67","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1574-695X.2007.00311.x","volume":"51","author":"P Tripathi","year":"2007","unstructured":"Tripathi P et al (2007) Immune response to leishmania: paradox rather than paradigm. FEMS Immunol Med Microbiol 51(2):229\u2013242","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10218_CR68","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ijbiomac.2018.08.125","volume":"120","author":"B Vakili","year":"2018","unstructured":"Vakili B et al (2018) Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum. Int J Biol Macromol 120:1127\u20131139","journal-title":"Int J Biol Macromol"},{"key":"10218_CR69","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3389\/fimmu.2018.03054","volume":"9","author":"E Wangkahart","year":"2019","unstructured":"Wangkahart E et al (2019) Studies on the use of flagellin as an immunostimulant and vaccine adjuvant in fish aquaculture. Front Immunol 9:3054","journal-title":"Front Immunol"},{"key":"10218_CR70","doi-asserted-by":"crossref","unstructured":"Wiederstein, M. and M. J. Sippl (2007). \"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins.\" Nucleic acids research 35(suppl_2): W407-W410.","DOI":"10.1093\/nar\/gkm290"},{"issue":"10","key":"10218_CR71","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.pnsc.2008.12.007","volume":"19","author":"J Zhang","year":"2009","unstructured":"Zhang J et al (2009) Design and optimization of a linker for fusion protein construction. Prog Nat Sci 19(10):1197\u20131200","journal-title":"Prog Nat Sci"}],"container-title":["International Journal of Peptide Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10989-021-10218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10989-021-10218-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10989-021-10218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:57:36Z","timestamp":1744185456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10989-021-10218-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10218"],"URL":"https:\/\/doi.org\/10.1007\/s10989-021-10218-8","relation":{},"ISSN":["1573-3149","1573-3904"],"issn-type":[{"value":"1573-3149","type":"print"},{"value":"1573-3904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]},"assertion":[{"value":"10 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}